Recruiting

Observational Study

Sponsor:

University of Pennsylvania

Code:

NCT01510067

Conditions

Cutaneous Lupus Erythematosus (CLE)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The Cutaneous Lupus Erythematosus (CLE) database, established in 2006, is a multi-site database between the University of Pennsylvania and the University of Texas Southwestern (UTSW).

Conditions

Cutaneous Lupus Erythematosus (CLE)

Study ID

NCT01510067

Start date

Dec, 2006

Status verified date

Mar, 2026

Completion date

Jan 2, 2030

Anticipated

Primary completion date

Jan 2, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Subjects who meet the criteria for having CLE, using the Gilliam classifications, and/or a diagnosis of systemic lupus erythematosus (SLE), using the American Rheumatism Association/American College of Rheumatology criteria. Subjects must be 18 years or older.

Exclusion Criteria:

  • All subjects who do not meet the criteria for having CLE. Subjects who meet the criteria for CLE but who are not yet 18 years old

Study Design

Enrollment

700 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Victoria P Werth, MD

215-615-2940werth@pennmedicine.upenn.edu

Joyce Okawa, R.N

215-615-2940Joyce.Okawa@pennmedicine.upenn.edu

Locations

Hospital of the University of Pennsylvania

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Contacts

Victoria P Werth, MD

215-615-2940werth@pennmedicine.upenn.edu

Joyce Okawa, RN

215-615-2940joyce.okawa@pennmedicine.upenn.edu

University of Texas Southwestern

Recruiting

Dallas, Texas, United States, 75390

More Information

Sponsor

University of Pennsylvania

Last update posted

Mar 30, 2026

Last verified

Mar, 2026

Keywords

  • CLE
  • Lupus
  • Lupus Erythematosus

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Pennsylvania on 2026-03-30.